Grosspeter Tower – Basel’s sustainable model skyscraper
With the ambitious goal of being a zero-emission building, Basel’s youngest skyscraper Grosspeter Tower was constructed to cover its own power requirements. Already during the construction phase, this impressive 78 meter office building by Burckhardt+Partner was awarded numerous prizes for its unique sustainable design and its building fabric. In particular, the façade, which is half windows, half integrated photovoltaic system - the first of its kind in Europe – make the building an efficient powerhouse.
Grosspeter Tower (img: Adriano Biondo)
After the official opening of Grosspeter Tower and move-in of Bayer in summer 2018, other well-known tenants have settled in the tower or will move into their newly developed offices in the coming months. Among others, Basel’s first Spaces Coworking solution operated by IWG will open its doors on the top floors from April 2019.
IWG – a leading provider of flexible workspaces – is strongly expanding in the Basel Region, aiming at establishing up to 10 new centers within the next three years. IWG has been a strong partner of BaselArea.swiss since opening its first center in Basel and has since hosted numerous foreign companies while starting up their business operations in the Basel region. To strengthen this partnership, BaselArea.swiss collaborates with IWG to offer its newly established Swiss entities of foreign companies and startups a soft start by providing free workspace for the first two months.
The building is ideally located in Basel’s business district, just a short walk from the railway station, shops and restaurants and has direct highway access. With the attached Ibis Styles, it offers on-site accommodation for business partners and customers.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More